Re: " EU was fine with the first manufacturer at the time of their inspection ...so they may be staying with that Co . Apparently there was only 1 issue FDA flagged"
That is precisely what I am thinking, they most likely want to get approval from the original submission, and regarding their sending the CEO to live there, I think they may want to send Pramod Gupta, Ph.D. (Executive Vice President of Pharmaceutical & Business Operations) as he might be better qualified to make certain that the manufacturer has dotted the i's and crossed the t's necessary for acceptance by the FDA.
Market Data 
Markets 
AI
